An RNA polymerase II elongation factor encoded by the human ELL gene

Science
A ShilatifardJ W Conaway

Abstract

The human ELL gene on chromosome 19 undergoes frequent translocations with the trithorax-like MLL gene on chromosome 11 in acute myeloid leukemias. Here, ELL was shown to encode a previously uncharacterized elongation factor that can increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by polymerase at multiple sites along the DNA. Functionally, ELL resembles Elongin (SIII), a transcription elongation factor regulated by the product of the von Hippel-Lindau (VHL) tumor suppressor gene. The discovery of a second elongation factor implicated in oncogenesis provides further support for a close connection between the regulation of transcription elongation and cell growth.

References

Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·H SerizawaJ W Conaway
May 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·G A RiceM J Chamberlin
Nov 22, 1991·Science·E SolomonA D Goddard
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R C Conaway, J W Conaway
Nov 1, 1995·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·T AsoR C Conaway
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·K P GarrettJ W Conaway
Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·P H DomerS J Korsmeyer
May 26, 1995·The Journal of Biological Chemistry·N F Marshall, D H Price
Nov 10, 1994·Nature·T H Rabbitts
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·M J ThirmanJ D Rowley
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·K P GarrettR C Conaway
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J CorralA Karpas
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·T NakamuraP C Nowell

❮ Previous
Next ❯

Citations

Dec 19, 2000·Biochemical and Biophysical Research Communications·K MitaniH Hirai
Mar 2, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Nanhai He, Qiang Zhou
Jul 1, 2011·Immunologic Research·Patricia SantosChristine Milcarek
Jan 29, 2008·International Journal of Hematology·Yali Dou, Jay L Hess
Sep 28, 2012·International Journal of Hematology·Young Rock ChungOmar Abdel-Wahab
Mar 17, 2004·Biochimica Et Biophysica Acta·Ali Shilatifard
Sep 6, 2002·Biochimica Et Biophysica Acta·Averell Gnatt
Sep 6, 2002·Biochimica Et Biophysica Acta·Rachel N Fish, Caroline M Kane
Jan 10, 2002·Biochimica Et Biophysica Acta·I Muyrers-Chen, R Paro
Jun 7, 1997·Biochimica Et Biophysica Acta·L Wolff
Aug 1, 2000·Trends in Biochemical Sciences·J W ConawayR C Conaway
Sep 1, 1996·Trends in Biochemical Sciences·D ReinesR C Conaway
Aug 8, 2013·Chemical Reviews·Jiannan Guo, David H Price
Jun 26, 2013·Chemical Reviews·Huasong LuQiang Zhou
Jan 19, 2012·Nature Communications·Jung S ByunKevin Gardner
Oct 25, 2007·Nature Reviews. Cancer·Andrei V Krivtsov, Scott A Armstrong
Sep 17, 2010·Nature Reviews. Cancer·Man MohanAli Shilatifard
Aug 17, 2012·Nature Reviews. Molecular Cell Biology·Zhuojuan LuoAli Shilatifard
Sep 1, 1999·British Journal of Haematology·J F Dimartino, M L Cleary
Jul 31, 1998·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Y TairaS Natori
Nov 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jung S ByunKevin Gardner
Sep 8, 2011·Proceedings of the National Academy of Sciences of the United States of America·Debabrata BiswasRobert G Roeder
Dec 20, 2012·Proceedings of the National Academy of Sciences of the United States of America·Seemay ChouTom Alber
Oct 16, 2013·Proceedings of the National Academy of Sciences of the United States of America·Sophie MourguesGiuseppina Giglia-Mari
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·J WuJ D Friesen
Jul 3, 2009·The Journal of Biological Chemistry·Ozan AygünJesper Q Svejstrup
Dec 3, 2005·The Cerebellum·Emmanuelle Bitoun, Kay Elizabeth Davies
Jan 18, 2011·Antioxidants & Redox Signaling·Ingolf E BlasigReiner F Haseloff
Apr 11, 2003·Molecular Biology of the Cell·Paul E PolakMichael J Thirman
Sep 26, 1997·Genes & Development·H R WilsonD L Court
Apr 5, 2011·Genes & Development·Edwin SmithAli Shilatifard

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved